444 related articles for article (PubMed ID: 8861994)
1. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.
Siegel JE; Weinstein MC; Russell LB; Gold MR
JAMA; 1996 Oct 23-30; 276(16):1339-41. PubMed ID: 8861994
[TBL] [Abstract][Full Text] [Related]
2. Recommendations of the Panel on Cost-effectiveness in Health and Medicine.
Weinstein MC; Siegel JE; Gold MR; Kamlet MS; Russell LB
JAMA; 1996 Oct; 276(15):1253-8. PubMed ID: 8849754
[TBL] [Abstract][Full Text] [Related]
3. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine.
Russell LB; Gold MR; Siegel JE; Daniels N; Weinstein MC
JAMA; 1996 Oct; 276(14):1172-7. PubMed ID: 8827972
[TBL] [Abstract][Full Text] [Related]
4. Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I.
Hay JW; Smeeding J; Carroll NV; Drummond M; Garrison LP; Mansley EC; Mullins CD; Mycka JM; Seal B; Shi L
Value Health; 2010; 13(1):3-7. PubMed ID: 19874571
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
Sanders GD; Neumann PJ; Basu A; Brock DW; Feeny D; Krahn M; Kuntz KM; Meltzer DO; Owens DK; Prosser LA; Salomon JA; Sculpher MJ; Trikalinos TA; Russell LB; Siegel JE; Ganiats TG
JAMA; 2016 Sep; 316(10):1093-103. PubMed ID: 27623463
[TBL] [Abstract][Full Text] [Related]
7. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
[TBL] [Abstract][Full Text] [Related]
8. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
9. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
10. Is the societal perspective in cost-effectiveness analysis useful for decision makers?
Russell LB; Fryback DG; Sonnenberg FA
Jt Comm J Qual Improv; 1999 Sep; 25(9):447-54. PubMed ID: 10481813
[TBL] [Abstract][Full Text] [Related]
11. Future Directions for Cost-effectiveness Analyses in Health and Medicine.
Neumann PJ; Kim DD; Trikalinos TA; Sculpher MJ; Salomon JA; Prosser LA; Owens DK; Meltzer DO; Kuntz KM; Krahn M; Feeny D; Basu A; Russell LB; Siegel JE; Ganiats TG; Sanders GD
Med Decis Making; 2018 Oct; 38(7):767-777. PubMed ID: 30248277
[TBL] [Abstract][Full Text] [Related]
12. Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine.
Padula WV; McQueen RB; Pronovost PJ
Med Care; 2017 Nov; 55(11):909-911. PubMed ID: 29028753
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review.
Ruiz-Negrón N; Menon J; King JB; Ma J; Bellows BK
Pharmacoeconomics; 2019 May; 37(5):669-688. PubMed ID: 30637713
[TBL] [Abstract][Full Text] [Related]
14. Reporting Quality of Cost-Effectiveness Analyses Conducted in Saudi Arabia: A Systematic Review.
Algarni MA; Alqahtani SS; Alshehri AM; Alanazi AS; Alzahrani MS; Alolayan SO; Alzarea AI
Value Health Reg Issues; 2021 Sep; 25():99-103. PubMed ID: 33848894
[TBL] [Abstract][Full Text] [Related]
15. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
16. Survival time outcomes in randomized, controlled trials and meta-analyses: the parallel universes of efficacy and cost-effectiveness.
Guyot P; Welton NJ; Ouwens MJ; Ades AE
Value Health; 2011; 14(5):640-6. PubMed ID: 21839400
[TBL] [Abstract][Full Text] [Related]
17. Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research.
Am J Respir Crit Care Med; 2002 Feb; 165(4):540-50. PubMed ID: 11850349
[TBL] [Abstract][Full Text] [Related]
18. Has the time come for cost-effectiveness analysis in US health care?
Bryan S; Sofaer S; Siegelberg T; Gold M
Health Econ Policy Law; 2009 Oct; 4(Pt 4):425-43. PubMed ID: 19203399
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analyses in orthopaedic sports medicine: a systematic review.
Nwachukwu BU; Schairer WW; Bernstein JL; Dodwell ER; Marx RG; Allen AA
Am J Sports Med; 2015 Jun; 43(6):1530-7. PubMed ID: 25125693
[TBL] [Abstract][Full Text] [Related]
20. Costing and perspective in published cost-effectiveness analysis.
Neumann PJ
Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
